Top Buy
| Security | Buy | Sell | Buy (1M) ▼ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Abeona Therapeutics Inc. | 7 | 1 | 1 | 0 | €4.52 | €16.61 | 267.566% |
| AstraZeneca plc | 3 | 0 | 1 | 0 | €153.50 | €167.75 | 9.283% |
| Aclaris Therapeutics Inc | 2 | 0 | 1 | 0 | €1.07 | €3.00 | 180.112% |
| BeiGene Ltd ADR | 9 | 1 | 1 | 0 | €177.00 | €241.54 | 36.465% |
| Gilead Sciences Inc | 12 | 1 | 1 | 0 | €66.71 | €84.81 | 27.135% |
| Codexis Inc. | 7 | 1 | 1 | 0 | €2.61 | €8.83 | 238.914% |
| Iovance Biotherapeutics Inc. | 21 | 2 | 1 | 0 | €9.39 | €26.24 | 179.344% |
| EyePoint Pharmaceuticals Inc. | 20 | 1 | 1 | 0 | €6.98 | €27.98 | 300.644% |
| Sanofi S.A. | 4 | 0 | 1 | 0 | €98.52 | €100.00 | 1.502% |
| Akebia Therapeutics Inc. | 7 | 2 | 0 | 0 | €1.31 | €3.64 | 179.051% |
| Chromadex Corp | 10 | 1 | 0 | 0 | €2.70 | €5.55 | 105.689% |
| Brainstorm Cell | 2 | 0 | 0 | 0 | €0.26 | €1.84 | 597.154% |
| Madrigal Pharmaceuticals inc. | 3 | 0 | 0 | 0 | €224.90 | €315.00 | 40.062% |
| Valneva SE | 1 | 0 | 0 | 0 | €3.37 | - | - |
| Novocure Ltd | 1 | 1 | 0 | 0 | €16.92 | - | - |
| Personalis Inc | 7 | 1 | 0 | 0 | €5.04 | - | - |
| Polynovo Ltd | 1 | 0 | 0 | 0 | €1.46 | - | - |
| Precision BioSciences Inc | 8 | 0 | 0 | 0 | €0.35 | €10.38 | 2881.839% |
| Taro Pharmaceutical Industries Ltd | 9 | 0 | 0 | 0 | €40.00 | - | - |
| Kala Pharmaceuticals Inc. | 4 | 0 | 0 | 0 | €5.28 | €18.02 | 241.377% |
| G1 Therapeutics | 20 | 1 | 0 | 0 | €6.43 | €11.09 | 72.595% |
| Avid Bioservices Inc | 2 | 0 | 0 | 0 | €9.50 | €10.00 | 5.263% |
| Akero Therapeutics Inc | 18 | 0 | 0 | 0 | €22.15 | €38.62 | 74.371% |
| Cocrystal Pharma Inc. | 6 | 0 | 0 | 0 | €1.52 | €9.24 | 507.632% |
| Blueprint Medicines Corp | 1 | 0 | 0 | 0 | €86.22 | - | - |